UBS AM
TSVT

UBS AM’s 2seventy bio TSVT Stock Holding History

UBS AM’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,868
Closed -$172K – 2604
2023
Q3 		$172K Hold
43,868
– – ﹤0.01% 2530
2023
Q2 		$447K Hold
43,868
– – ﹤0.01% 2368
2023
Q1 		$447K Sell
43,868
-3,369
-7% -$38.5K ﹤0.01% 2368
2022
Q4 		$443K Hold
47,237
– – ﹤0.01% 2223
2022
Q3 		$687K Buy
47,237
+1,646
+4% +$24.4K ﹤0.01% 2181
2022
Q2 		$602K Buy
45,591
+35,558
+354% +$485K ﹤0.01% 2234
2022
Q1 		$171K Hold
10,033
– – ﹤0.01% 2701
2021
Q4 		$257K Buy
+10,033
New +$313K ﹤0.01% 2712

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

UBS AM's TSVT Position: Q4 2023 in Review

UBS AM sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 43,868 shares — an estimated $172K sold.

UBS AM first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $687K in Q3 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • UBS AM reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • UBS AM sold 43,868 2seventy bio shares in Q4 2023, an estimated $172K.
  • UBS AM first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • UBS AM's 2seventy bio position peaked at $687K in Q3 2022.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.